Application of periplogenin in preparation of medicine for preventing APAP-induced medicine-induced liver injury
By inhibiting the NF-κB signaling pathway, leverinosin significantly alleviates APAP-induced drug-induced liver injury, solves the problems of limited efficacy and major side effects in the prior art, and provides a more effective treatment plan for liver injury.
Patent Information
- Application Number
- CN202411235763.4
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-09-04
- Publication Date
- 2024-11-08
AI Technical Summary
The prior art is limited in the treatment of drug-induced liver injury, especially liver injury induced by acetaminophen (APAP), and lacks effective treatment methods with small side effects.
By inhibiting the NF-κB signaling pathway, leverinones are used to reduce the expression of inflammatory factors, protect the liver, significantly improve the liver and spleen index, reduce malondialdehyde and improve superoxide dismutase activity, and reduce liver tissue damage.
Galligenin significantly alleviates drug-induced liver injury induced by APAP, and verifies its protective role in preventing APAP-induced liver injury through in vivo and in vitro experiments, providing a more effective treatment plan with less side effects.
Smart Images

Figure CN118903158A_ABST
Abstract
Description
Technical Field
[0001] The invention relates to the technical field of biomedicine, and in particular to application of periplocin in preparing a medicine for preventing APAP-induced drug-induced liver injury. Background Art
[0002] Drug-induced liver injury (DILI) is the main cause of acute liver failure, accounting for more than half of all acute liver failure cases. Acetaminophen (APAP) has been widely used, and overdose can lead to severe hepatocellular necrosis and liver failure. APAP is metabolized by the liver to produce non-toxic metabolites at normal doses, but in overdose, it will generate the toxic intermediate N-acetyl-p-benzoquinone imine (NAPQI) through the cytochrome P450 enzyme system (especially CYP2E1, CYP3A4 and CYP1A2). Hepatocyte proteins and DNA are covalently linked after excessive NAPQI consumes intracellular glutathione (GSH). NAPQI depletes glutathione (GSH) reserves in hepatocytes, triggers oxidative stress, and leads to hepatocyte damage and inflammatory response. Currently, N-acetylcysteine (NAC) is the main antidote used clinically to treat APAP poisoning. NAC reduces the toxicity of NAPQI by supplementing GSH and enhancing the liver's detoxification capacity. However, the efficacy of NAC is only significant in the early stage of APAP poisoning, and it is accompanied by side effects such as vomiting, headache, and nausea. Therefore, there is an urgent need to develop more effective treatments with fewer side effects.
[0003] In recent years, many studies have begun to focus on the protective effects of natural products in liver injury. For example, silymarin has been widely studied. Its main active ingredient is silibinin, which has significant antioxidant and anti-inflammatory effects and has been shown to effectively reduce APAP-induced liver injury. In addition, curcumin, as a natural polyphenol compound, has also become a hot topic of research due to its anti-inflammatory, antioxidant and anti-cancer properties. Studies have shown that curcumin can reduce APAP-induced liver injury by inhibiting oxidative stress and inflammatory pathways. Periploca sepium Bunge is a plant of the genus Periploca in the Asclepiadaceae family. The dried root bark of Periploca sepium Bunge is the traditional Chinese medicine "Xiangjiapi", also known as "Beiwujiapi". At present, 4 cardiac glycosides have been isolated and identified from the root bark of Periploca sepium Bunge, including 2 aglycones and 2 glycosides, all of which are alpha-type cardiac glycosides. Literature reports that periploxin should be the material basis for the anti-inflammatory effect of Cortex Periplocae, or at least one of the material bases for its pharmacological effects. In addition, periploxin may have the ability to improve immune disorders by inhibiting inflammatory responses. These findings suggest that periploxin may be a valuable candidate for the development of new therapies for cancer, inflammatory diseases, and other immune diseases. However, the hepatoprotective activity of periploxin has not been reported.
[0004] In view of the above-mentioned defects, the inventors of the present invention finally obtained the present invention after a long period of research and practice. Summary of the invention
[0005] The purpose of the present invention is to solve the problem of how to apply the natural product periploxin to protect liver damage, and provide the application of periploxin in preparing a drug for preventing APAP-induced drug-induced liver damage.
[0006] In order to achieve the above object, the present invention discloses the use of periplocidin in the preparation of a drug for preventing APAP-induced drug-induced liver injury. The structural formula of the periplocidin is as follows:
[0007]
[0008] The periplocaine inhibits the expression of IL-6, TNF-α and IL-1β in AML-12 cells induced by APAP.
[0009] The periploca aglycone inhibits the NF-κB signaling pathway through PDTC.
[0010] Compared with the prior art, the beneficial effect of the present invention is that: the present invention constructs an APAP-induced mouse drug-induced liver injury model through in vivo and in vitro experiments, evaluates the changes in survival rate and liver and spleen index, and uses HE staining to observe the pathological changes in the liver tissue of each group of mice. Elisa and Western blot techniques were used to analyze the effect of Ppg on the expression of inflammatory factors and related signaling pathway proteins in APAP-induced AML-12 cells, and glutathione (GSH), malondialdehyde (MDA) levels and superoxide dismutase (SOD) activity were detected at the same time. The results of in vivo experiments showed that Ppg significantly improved the liver and spleen index of mice with acute liver injury and alleviated the pathological damage of liver tissue. In vitro experiments showed that Ppg significantly inhibited the expression of IL-6, TNF-α and IL-1β in APAP-induced AML-12 cells, reduced the levels of GSH and MDA, and increased the activity of SOD. At the same time, the NF-κB signaling pathway was inhibited by PDTC (NF-κB signaling pathway inhibitor), the expression of inflammatory factors was reduced, and the accumulation of p65 in the cell nucleus was significantly reduced. Salicylate aglycone can alleviate liver damage caused by APAP, and its molecular mechanism may be to inhibit the NF-κB signaling pathway in hepatocytes, thereby inhibiting the inflammatory response and protecting the liver of APAP-induced mice. BRIEF DESCRIPTION OF THE DRAWINGS
[0011] Figure 1 is the chemical structural formula of Periploca aglycone;
[0012] Figure 2 The effect of Ppg on APAP-induced liver injury in mice, A is the liver index of mice, B is the spleen index of mice;
[0013] Figure 3 The effect of Ppg on liver tissue damage and oxidation index in mice. A is the effect of different doses of Periploca aglycone on liver damage, which visually observes the liver damage of mice in different treatment groups. B: HE staining observes the therapeutic effect of different doses of Periploca aglycone on APAP-induced drug-induced liver damage. C is the level of MDA, D is the intracellular GSH content, and E is the SOD activity.
[0014] Figure 4 The effect of Ppg on the secretion of inflammatory factors in APAP-induced AML-12 hepatocyte injury. AB: protein expression and quantitative analysis of IL-6, IL-1β, and TNF-α. CD: ELISA experiments to verify the content of IL-6, IL-1β, and TNF-α in the cell supernatant.
[0015] Figure 5The effect of Ppg on the expression level of key proteins of NF-κB pathway in APAP-induced drug-induced liver injury cell model. A is the expression of p65 and p-p65 proteins, and B is the gray value analysis of p65 and p-p65 proteins.
[0016] Figure 6 The effect of Ppg on the nuclear expression level of NF-κB p65 in the NF-κB pathway in the APAP-induced drug-induced liver injury cell model was analyzed by AB for immunofluorescence (IF) detection and semi-quantitative analysis of p65 expression and localization in the NF-κB signaling pathway;
[0017] Figure 7 is the effect of NF-κB inhibitor PDTC on inflammatory factors in the cell model of drug-induced liver injury, and AB is the protein expression of IL-6, IL-1β, and TNF-α after adding PDTC inhibitor;
[0018] Figure 8 The expression levels of key proteins of the NF-κB pathway in the cell model of APAP-induced drug-induced liver injury were affected by the NF-κB inhibitor PDTC. DETAILED DESCRIPTION
[0019] The above and other technical features and advantages of the present invention are described in more detail below in conjunction with the accompanying drawings.
[0020] 1. Materials
[0021] 1. Drugs and reagents
[0022] Ppg (Periplogenin, product number HY-N2414, batch number 280111, purity > 98%, MCE); APAP (Acetaminophen, product number HY-66005, batch number 103902, purity > 98%, MCE); Bicyclol tablets (product number HY-B0766, batch number 21457, MCE); PDTC (Pyrrolidinedithiocarbamate, product number HY-18738, batch number 28990); ultrasensitive luminescence solution (Biosharp); BCA protein concentration assay kit (enhanced) (Beyotime Biotechnology, product number P0010S); PMSF and RIPA lysis buffer (Biosharp); IL-6 mouse inflammation kit (Quanzhou Ruixin Biotechnology Co., Ltd., product number RX203049M); IL-1β mouse inflammation kit (Quanzhou Ruixin Biotechnology Co., Ltd., product number RX203063M); TNF-α mouse inflammation kit (Quanzhou Ruixin Biotechnology Co., Ltd., product number RX202412M); malondialdehyde (MDA) assay kit (Nanjing Jiancheng Bioengineering Institute, product number A003-1-2); reduced glutathione (GSH) assay kit (Nanjing Jiancheng Bioengineering Institute, product number A006-2-1); SOD kit (Nanjing Jiancheng Bioengineering Institute, product number A001-3-1); IL-1β (Affinity, product number AF5103); IL-6 (Affinity, product number DF6087); TNF-α (Affinity, product number AF7014); p65 primary antibody (Affinity, product number AF5006); p-p65 primary antibody (Affinity, product number AF2006); goat anti-mouse IgG (Zs-BIO, product number ZB-2305); goat anti-rabbit IgG (Zs-BIO, product number ZB-2301).
[0023] 2. Experimental animals
[0024] SPF-grade male C57BL / 6 mice, 6 weeks old, weighing 18 - 22 g, were purchased from the Experimental Animal Center of Anhui Medical University and housed in this center with free access to food and water. The animal certificate number is SCXK(Yu)2020 - 0005. The experiment was carried out strictly in accordance with the animal use and management regulations of the state and the Experimental Animal Center of Anhui Medical University.
[0025] 3. Instruments
[0026] LiCor Odyssey developer (Bio-Rad, USA), inverted fluorescence microscope (YIB510FL) (Suzhou Yueshi Precision Instrument Co., Ltd.), constant temperature cell culture incubator (AC2-5S8-CN) (ESCO Group), ELISA analyzer (Raydu), EPS300 electrophoresis instrument (Shanghai Tianneng Technology Co., Ltd. (Tanon)), VE-186 membrane transfer instrument (Shanghai Tianneng Technology Co., Ltd. (Tanon)).
[0027] 2. Methods
[0028] 1. Animal grouping and drug administration
[0029] Thirty C57BL / 6 mice, male, 8 weeks old, weighing 18-22g, were purchased from the Experimental Animal Center of Anhui Medical University and fed freely. After one week of adaptive feeding, the mice were randomly divided into the following groups (5 mice in each group): normal control group (control group, C), model group (model group, M), low-dose group (PL, 5mg·kg-1) of Ppg, medium-dose group (PM, 25mg·kg-1) of Ppg, high-dose group (PH, 40mg·kg-1) of Ppg, and positive control group (Bicyclol, 200mg·kg-1). The administration method was intraperitoneal injection, once a day, for 7 consecutive days. Two hours after the last administration, mice in the M group, PL group, PM group, PH group and positive control group were intraperitoneally injected with 250mg / kg APAP (dissolved in 0.1% carboxymethylcellulose sodium salt solution, CMC-Na), and mice in the normal control group were intraperitoneally injected with an equal volume of CMC-Na solution. The mice were kept for 12 h without food or water restriction and then euthanized with 2% isoflurane, and the liver and spleen were removed for subsequent analysis.
[0030] 2. Determination of liver index
[0031] Each experimental mouse was weighed before euthanasia, and then the liver and spleen tissues were removed, washed with saline, and the surface moisture was absorbed with filter paper. The liver and spleen indexes were weighed and calculated respectively.
[0032] 3. Pathological tissue testing
[0033] Liver tissues were fixed in 4% paraformaldehyde solution, dehydrated with gradient ethanol, and embedded in paraffin. The slices were 5 μm thick and stained with HE. After sealing, the slices were placed under an optical microscope to observe the histopathological changes and were photographed for analysis.
[0034] 4. Cell culture
[0035] Mouse hepatocyte AML-12 cells were cultured in high-glucose DMEM medium containing 10% fetal bovine serum (FBS) and supplemented with 1% penicillin-streptomycin (100 U / mL). Cell culture conditions were 37°C, 5% CO2, and 95% humidity in an incubator. Cell morphology was observed daily under an inverted microscope, and the culture medium was replaced every 1-2 days.
[0036] 5. Cell processing and grouping
[0037] Each cell was 2×10 5 The cells were seeded at a density of 1.547 W / well in a 6-well plate. After incubation for 24 h, culture medium containing different concentrations of Pgg (2, 8 and 16 μM) was added. Three replicate wells were set up in each group and incubation was continued for 24 h. Subsequently, the cells were divided into the following groups: normal group (Normal) and model group (Model, APAP 5 mM). Culture medium containing 5 mM APAP was added to the model group and incubated for 4 h to complete the APAP-induced liver injury model.
[0038] 6. Detection of intracellular biochemical indicators
[0039] After treating the cells, wash the cells twice with PBS. Use a cell scraper to scrape the cells (avoid using trypsin and EDTA), and add 2-5mL PBS to collect the cell suspension. Strictly follow the instructions of the kit to detect the content of IL-1β, IL-6, TNF-α, GSH, SOD and MDA in the cell supernatant.
[0040] 7. Western blot method to detect the expression level of related proteins in cells
[0041] After cell treatment, protein quantification was performed first, and loading buffer was added. The sample was boiled in boiling water for 20 minutes to ensure complete denaturation of the protein. SDS-PAGE gel electrophoresis was then performed to separate the proteins, and after electrophoresis, the proteins were transferred to a PVDF membrane. After transfer, the nonspecific binding sites on the membrane were blocked with blocking solution, and then the primary antibody was added and incubated overnight at 4°C. On d 2, the PVDF membrane was washed three times with TBST for 5 minutes each to remove the unbound primary antibody. Then, the secondary antibody was added and incubated at room temperature for 1 hour. The PVDF membrane was washed again with TBST three times for 5 minutes each. Subsequently, ECL chemiluminescent reagent was used for development, and the protein band images were collected using a UVP gel imaging system. Image J software was used for quantitative analysis, with β-actin as the internal reference protein (for phosphorylated proteins, the corresponding total protein was used as the internal reference) to calculate the relative expression of the target protein.
[0042] 8. Immunofluorescence detection
[0043] Paraffin sections were taken and operated according to the requirements of the immunofluorescence kit, and PBS was used for washing. The nuclear translocation of NF-κB was shown under a fluorescence microscope, and the average optical density was determined by image analysis software.
[0044] 9. Statistical analysis
[0045] Statistical analysis was performed using Prism.9 software and one-way ANOVA test, with data presented as x±s. The t test was used for comparison between groups, with P<0.05 considered significant.
[0046] 3. Results
[0047] 1. Chemical structure of Ppg
[0048] Ppg is a cardiac glycoside compound extracted from the root bark of Periploca sepium Bunge, a traditional Chinese medicine. Its chemical structure is as follows: Figure 1 As shown. The chemical structure of Ppg shows that it is a steroidal glycoside with multiple ring structures, which has significant anti-inflammatory, antioxidant and immunomodulatory effects. This compound exerts its pharmacological activity through multiple pathways, providing a theoretical basis for studying its protective effect in drug-induced liver injury.
[0049] 2. Ppg alleviates APAP-induced drug-induced liver injury
[0050] like Figure 2 As shown, the liver and spleen index results showed that the APAP-induced liver injury model was successfully established. The liver index is an indicator reflecting the relative weight of the liver, usually expressed as a percentage of liver weight to body weight. Changes in the liver index can reflect the degree of inflammation and damage to the liver. In this study, the determination of the liver index was used to evaluate the protective effect of periplocidin on APAP-induced liver injury. By comparing the liver index of mice in different treatment groups, we can understand whether periplocidin can effectively reduce liver damage and maintain normal liver function.
[0051] The spleen index is an indicator that reflects the relative weight of the spleen, usually expressed as a percentage of spleen weight to body weight. Changes in the spleen index can reflect the body's immune status and inflammatory response. In the drug-induced liver injury model, the determination of the spleen index is used to assess the extent of the inflammatory response. By comparing the spleen index of mice in different treatment groups, we can understand whether Periploca aglycone can alleviate liver injury by regulating immune and inflammatory responses.
[0052] Compared with the model group, the spleen index was significantly reduced in the low-dose Ppg group (PL, 5 mg / kg), medium-dose Ppg group (PM, 25 mg / kg), high-dose Ppg group (PH, 40 mg / kg) and positive control group (Bicyclol, 200 mg / kg) (P<0.01). There was no significant effect of Ppg groups on the liver index, but there was a trend to reduce the liver index (P>0.05).
[0053] 3. Effect of Ppg on pathological changes of mouse liver tissue
[0054] HE staining was further used to observe the damage of mouse liver tissue. HE staining is a commonly used staining method in pathology, which can clearly show the tissue structure and cell morphology. Through HE staining, the pathological changes of mouse liver tissue can be observed, including pathological characteristics such as cell necrosis, inflammatory infiltration, and hepatocyte degeneration, so as to evaluate the degree of liver damage. In this study, HE staining was used to compare the pathological changes of mouse liver tissue in different treatment groups, so as to evaluate the protective effect of periploxin on APAP-induced liver damage. Through HE staining, it can be intuitively seen whether periploxin can reduce the pathological damage of the liver, such as reducing the necrotic area and reducing the inflammatory response.
[0055] like Figure 3 As shown, the results showed that the liver tissue sections of mice in the control group showed normal liver structure, with neatly arranged hepatocytes, clear central veins, and no signs of necrosis or inflammation. In contrast, the APAP-treated group showed significant liver damage, characterized by hepatocyte necrosis, inflammatory cell infiltration, and liver structural destruction. The groups that pre-administered Ppg and bicyclol to mice significantly reduced the number of vacuolated hepatocytes. Compared with the model group, the integrity of the liver lobule structure in the Ppg dose groups and the positive drug bicyclol group was improved to a certain extent, while hepatocyte necrosis was alleviated, inflammatory infiltration was reduced, and hepatocyte structure was improved.
[0056] 4. Effect of Ppg on lipid peroxidation level in APAP-induced drug-induced liver injury
[0057] The study showed that compared with the control group, the malondialdehyde (MDA) level in the APAP-induced model group (M group) was significantly increased (P < 0.01), indicating enhanced lipid peroxidation. In contrast, the superoxide dismutase (SOD) activity and reduced glutathione (GSH) levels were significantly decreased (P < 0.01), indicating that oxidative stress and antioxidant defense were impaired. Ppg dose groups (PL group, PM group, PH group) and the positive control group (Bicyclol group) significantly reduced the MDA content (P < 0.01), significantly increased the SOD enzyme activity (P < 0.01), and restored the GSH level to close to the normal level, highlighting its powerful antioxidant properties. The results of this experiment show that Ppg plays a protective role against APAP-induced acute liver injury by affecting the oxidation / antioxidation balance ( Figure 3 BD).
[0058] 5. Effect of Ppg on the expression level of inflammatory factors in the in vivo model of APAP-induced drug-induced liver injury
[0059] The expression levels of IL-6, TNF-α and IL-1β in the liver cells of mice in the model group (M group) were significantly increased (P<0.01). Compared with the model group, the expression levels of IL-6 and TNF-α in the Ppg dose groups (PL group, PM group, PH group) and the positive control group (Bicyclol group) were significantly reduced (P<0.05), and the inhibitory effect on IL-1β was not statistically significant ( Figure 4 ).
[0060] IL-6, IL-1β, and TNF-α are the main proinflammatory cytokines, which play an important role in the inflammatory response. By measuring the secretion levels of these factors, the degree of inflammatory response in APAP-induced drug-induced liver injury can be directly evaluated. APAP-induced drug-induced liver injury is usually accompanied by the activation of the NF-κB signaling pathway, and the activation of the NF-κB pathway leads to increased expression of these inflammatory factors. By measuring the secretion levels of IL-6, IL-1β, and TNF-α, the activation state of the NF-κB pathway and its role in the inflammatory response can be indirectly evaluated. Studies have shown that periwinkle aglycone (Ppg) has a significant anti-inflammatory effect. By measuring the secretion levels of these three inflammatory factors, the anti-inflammatory effect of periwinkle aglycone in APAP-induced drug-induced liver injury can be verified.
[0061] 6. Effect of Ppg on key proteins of NF-κB pathway in APAP-induced drug-induced liver injury cell model
[0062] Western blot results showed that in the APAP-treated model group (M group), the expression of p-p65 was significantly increased (P < 0.01), indicating that the NF-κB pathway was activated. Compared with the model group, the expression level of p-p65 in each Ppg treatment group showed a downward trend, and the medium and high dose groups significantly downregulated the p-p65 protein level (P < 0.01), indicating that Ppg can inhibit the activation of the NF-κB signaling pathway, reduce the phosphorylation of p65, significantly reduce the inflammatory response, and reduce the production of inflammatory mediators ( Figure 5 ).
[0063] APAP-induced liver injury is usually accompanied by a strong inflammatory response, and the activation of the NF-κB pathway leads to increased expression of a series of proinflammatory factors. By detecting the levels of p65 and p-p65, we can further understand the regulatory mechanism of periplocidin on inflammatory response, especially its effect on the NF-κB signaling pathway.
[0064] 7. Effect of Ppg on nuclear translocation of NF-κB p65 protein in APAP-induced drug-induced liver injury cell model
[0065] Immunofluorescence (IF) detection analyzed the expression and localization of p65 in the NF-κB signaling pathway. Compared with the normal control group (N group), in the APAP-treated model group (M group), p65 protein accumulated significantly in the cell nucleus, indicating that the NF-κB pathway was activated. In the Ppg-treated groups (PL group, PM group, PH group), the accumulation of p65 in the cell nucleus was significantly reduced, especially in the medium and high dose groups (PM group, PH group), the effect was more significant, indicating that Ppg can inhibit the activation of the NF-κB signaling pathway and reduce the nuclear translocation of p65. This result supports the hypothesis that Ppg exerts anti-inflammatory effects by inhibiting the NF-κB pathway, providing direct evidence for its anti-inflammatory mechanism ( Figure 6 ).
[0066] The activation of the NF-κB pathway involves the transfer of the p65 subunit from the cytoplasm to the nucleus. This process is a key step for the NF-κB pathway to exert its transcriptional regulatory function. By fluorescently labeling the p65 protein, it is possible to visually observe whether p65 enters the nucleus, thereby confirming whether the NF-κB pathway is activated. Periploca aglycone is believed to have an anti-inflammatory effect. By verifying the nuclear expression of p65 by fluorescence, it is possible to evaluate whether periploca aglycone exerts its anti-inflammatory effect by inhibiting the activation of the NF-κB pathway. This helps to reveal the mechanism of action of periploca aglycone and evaluate its potential in preventing and treating APAP-induced drug-induced liver injury. Fluorescence labeling technology can not only qualitatively observe the nuclear localization of p65, but also provide quantitative information through fluorescence intensity. This is of great significance for evaluating the degree of activation of the NF-κB pathway and the regulatory effect of periploca aglycone.
[0067] 8. Effect of NF-kB inhibitor PDTC on inflammatory factors in drug-induced liver injury cell model
[0068] Compared with the APAP-induced group (M group), the PDTA-treated group (PDTA), as an NF-κB inhibitor, also significantly reduced the expression of these inflammatory factors, and the relative expression levels of IL-1β, IL-6, and TNF-α proteins were significantly reduced (P < 0.05), and the effect was similar to that of the periwinkle aglycone group (Ppg) ( Figure 7 ).
[0069] The NF-κB pathway plays a key role in the inflammatory response. By using PDTC (pyrrolidine dithiocarbamate), the activation of the NF-κB pathway can be specifically inhibited, thereby verifying the specific role of the NF-κB pathway in APAP-induced drug-induced liver injury. In the APAP-induced liver injury model, the activation of the NF-κB pathway leads to increased expression of a series of proinflammatory factors. By applying PDTC, changes in the expression of inflammatory factors (such as IL-6, IL-1β, TNF-α) after the NF-κB pathway is inhibited can be observed, thereby evaluating the regulation of these factors in the inflammatory response.
[0070] By comparing the levels of inflammatory factors after using PDTC and scutellariae aglycone, we can further understand whether the anti-inflammatory mechanism of scutellariae aglycone is related to the NF-κB pathway. If both can reduce the expression of inflammatory factors, it means that scutellariae aglycone may exert its anti-inflammatory effect by inhibiting the NF-κB pathway.
[0071] 9. Effect of NF-κB inhibitor PDTC on NF-κB signaling pathway in drug-induced liver injury cell model
[0072] The PDTA treatment group also significantly reduced the expression of p-p65, indicating its inhibitory effect on the NF-κB signaling pathway. The medium and high dose groups (PM, PH) of smilax glabra aglycone significantly reduced the expression of p-p65. The results were similar to those of the PDTA treatment group. The immunofluorescence results and Western blot results corroborated each other, showing the regulatory effect of Ppg on the NF-κB signaling pathway. The reliability and persuasiveness of the results were increased through cross-validation of multiple experimental methods ( Figure 8 ).
[0073] Periploca aglycone is considered to have anti-inflammatory effects. By measuring the expression of p65 and p-p65, it can be verified whether Periploca aglycone exerts its anti-inflammatory effect by inhibiting the activation of the NF-κB pathway, thereby revealing its potential mechanism in preventing and treating APAP-induced drug-induced liver injury.
[0074] In summary, APAP-induced liver injury involves multiple molecular mechanisms, among which the NF-κB signaling pathway plays a key role in the inflammatory response. The NF-κB family includes five members: p65 (RelA), RelB, c-Rel, p50 / p105 (NF-κB1) and p52 / p100 (NF-κB2).
[16] . These proteins regulate gene expression by forming homo- or heterodimers. The most common active form is a heterodimer formed by p65 and p50. NF-κB is a core regulator of inflammatory response. Its activation can lead to the expression of a variety of pro-inflammatory factors (such as IL-1β, IL-6, TNF-α), promoting the initiation and maintenance of inflammatory response. When exploring the effect of periwinkle aglycone Ppg on acute liver injury in mice induced by acetaminophen APAP, the present invention explored the effect of ppg on the protein expression of p65 and p-p65 in the NF-κB pathway of APAP-induced AML-12 cells. Phosphorylation of p65 usually aggravates the inflammatory response because phosphorylation enhances the transcriptional activity of p65, promotes the expression of inflammation-related genes, and leads to the production of more inflammatory mediators and anti-apoptotic proteins. In clinics and experiments, the inflammatory response can be effectively alleviated by inhibiting the phosphorylation of p65, so this mechanism is of great significance in the treatment of inflammatory diseases. The present invention shows that in the model group mice treated with APAP, p65 protein is translocated to the nucleus in large quantities, and the level of p-p65 protein is significantly increased, indicating that the NF-κB pathway is activated. The Ppg treatment group significantly reduced the nuclear accumulation of p65 and the expression of p-p65, indicating that Ppg can inhibit the activation of the NF-κB signaling pathway and reduce the phosphorylation and nuclear translocation of p65. The positive control group (Bicyclol) showed similar effects. These results clearly support the hypothesis that Ppg exerts an anti-inflammatory effect by inhibiting the NF-κB pathway, providing direct evidence for its anti-inflammatory mechanism. In addition, Ppg can significantly reduce the expression levels of IL-6, TNF-α and IL-1β in APAP-induced AML-12 cells, further verifying its anti-inflammatory effect. The reliability and persuasiveness of the research results are enhanced by cross-validation of two technical means, immunofluorescence and Western blot.
[0075] The present invention systematically evaluated the hepatoprotective effect and mechanism of Ppg through the APAP-induced drug-induced liver injury model. The results showed that Ppg not only alleviated liver damage through anti-inflammatory and anti-oxidative stress effects, but also reduced the expression of inflammatory factors by inhibiting the activation of the NF-κB signaling pathway. These findings provide an important theoretical basis and experimental basis for the development of new hepatoprotective drugs.
[0076] The above description is only a preferred embodiment of the present invention, which is only illustrative and not restrictive of the present invention. Those skilled in the art understand that many changes, modifications, and even equivalences may be made to the present invention within the spirit and scope defined by the claims of the present invention, but all of them will fall within the scope of protection of the present invention.
Claims
1. Application of periplocoside in the preparation of drugs for preventing APAP-induced drug-induced liver injury, It is characterized in that The structural formula of the perilla aglycone is as follows:
2. Use of the periplocin aglycone as claimed in claim 1 in the preparation of a medicament for preventing APAP-induced drug-induced liver injury, It is characterized in that The periplocaine inhibits the expression of IL-6, TNF-α and IL-1β in AML-12 cells induced by APAP.
3. Use of the periplocin aglycone as claimed in claim 1 in the preparation of a medicament for preventing APAP-induced drug-induced liver injury, It is characterized in that The periploca aglycone inhibits the NF-κB signaling pathway through PDTC.
Citation Information
Cited By
Application of periplocin in anti-hepatocellular carcinoma medicine and target screening method
CN119606983A
